Coyle D, Tolley K. Discounting of health benefits in the pharmacoeconomic analysis of drug therapies. Pharmacoeconomics. 1992;2(2):153–62.

Article
CAS
PubMed
Google Scholar

Claxton K, Paulden M, Gravelle H, Brouwer W, Culyer AJ. Discounting and decision making in the economic evaluation of health-care technologies. Health Econ. 2011;20(1):2–15.

Article
PubMed
Google Scholar

Schad M, John J. Towards a social discount rate for the economic evaluation of health technologies in Germany: an exploratory analysis. Eur J Health Econ. 2012;13(2):127–44.

Article
PubMed
Google Scholar

Bos JM, Postma MJ, Annemans L. Discounting health effects in pharmacoeconomic evaluations. Pharmacoeconomics. 2005;23(7):639–49.

Article
CAS
PubMed
Google Scholar

Attema AE, Brouwer WBF, Claxton C. Discounting in economic evalations. Pharmacoeconomics. 2018. https://doi.org/10.1007/s40273-018-0672-z.

Article
PubMed
PubMed Central
Google Scholar

Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG. Cost-effectiveness in health and medicine. 2nd ed. Oxford: Oxford University Press; 2016.

Book
Google Scholar

Sanders GD, Neumann PJ, Basu A, Brock DW, Feeny D, Krahn M, Kuntz KM, Meltzer DO, Owens DK, Prosser LA, Salomon JA, Sculpher MJ, Trikalinos TA, Russell LB, Siegel JE, Ganiats TG. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses. Second Panel on Cost-Effectiveness in Health and Medicine. JAMA. 2016;316(10):1093–103.

Article
PubMed
Google Scholar

Paulden M, O’Mahony JF, McCabe C. Discounting the recommendations of the Second Panel on Cost-Effectiveness in Health and Medicine. Pharmacoeconomics. 2017;35(1):5–13.

Article
PubMed
Google Scholar

Bos JM, Annemans L, Postma MJ. Valuing prevention through economic evaluation. Pharmacoeconomics. 2004;22(18):1171–9.

Article
PubMed
Google Scholar

Jit M, Mibei W. Discounting in the evaluation of the cost-effectiveness of a vaccination programme: a critical review. Vaccine. 2015;33(32):3788–94.

Article
PubMed
Google Scholar

Westra TA, Parouty M, Brouwer WB, Beutels PH, Rogoza RM, Rozenbaum MH, Daemen T, Wilschut JC, Boersma C, Postma M. On discounting of health gains from human papillomavirus vaccination: effects of different approaches. Value Health. 2012;15(3):562–7.

Article
PubMed
Google Scholar

Weinstein M, Stason W. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296(13):716–21.

Article
CAS
PubMed
Google Scholar

Keeler E, Cretin S. Discounting of life-saving and other non-monetary effects. Manag Sci. 1983;29(3):300–6.

Article
Google Scholar

Viscusi K. Discounting health effects for medical decisions. In: Sloan F, editor. Valuing health care. Cambridge: Cambridge University Press; 1995. p. 125–47.

Chapter
Google Scholar

Gravelle H, Smith D. Discounting for health effects in cost-benefit and cost-effectiveness analysis. Health Econ. 2001;10(7):587–99.

Article
CAS
PubMed
Google Scholar

Nord E. Discounting future health benefits: the poverty of consistency arguments. Health Econ. 2011;20(1):16–26.

Article
PubMed
Google Scholar

Welte R, Leidl R, Greiner W, Postma M. Health economics of infectious diseases. In: Krämer A, Kretzschmar M, Krickeberg K, editors. Modern infectious disease epidemiology: concepts, methods, mathematical models, and public health. Berlin: Springer; 2010. p. 249–76.

Google Scholar

Postma MJ, Parouty M, Westra TA. Accumulating evidence for the case of differential discounting. Expert Rev Clin Pharmacol. 2013;6(1):1–3.

Article
CAS
PubMed
Google Scholar

Brouwer W, Niessen L, Postma M, Rutten F. Need for differential discounting of costs and health effects in cost effectiveness analyses. BMJ. 2005;331(7514):446–8.

Article
PubMed
PubMed Central
Google Scholar

Brouwer W, van Hout B, Rutten F. A fair approach to discounting future effects: taking a societal perspective. J Health Serv Policy. 2000;5(2):114–8.

Article
CAS
Google Scholar

Claxton K, Sculpher M, Culyer A, McCabe C, Briggs A, Akehurst R, Buxton M, Brazier J. Discounting and cost-effectiveness in NICE—stepping back to sort out a confusion. Health Econ. 2006;15(1):1–4.

Article
PubMed
Google Scholar

Gravelle H, Brouwer W, Niessen L, Postma M, Rutten F. Discounting in economic evaluations: stepping forward towards optimal decision rules. Health Econ. 2007;16(3):307–17.

Article
PubMed
Google Scholar

Klok RM, Brouwer WBF, Annemans LJP, Bos JM, Postma MJ. Towards a healthier discount procedure. Expert Rev Pharmacoecon Outcomes Res. 2005;5(1):59–63.

Article
Google Scholar

Lazaro A. Theoretical arguments for the discounting of health consequences. Where do we go from here? Pharmacoeconomics. 2002;20(14):943–61.

Article
PubMed
Google Scholar

Van Hout BA. Discounting costs and effects: a reconsideration. Health Econ. 1998;7(7):581–94.

Article
PubMed
Google Scholar

Hammit JK. Discounting health and cost-effectiveness analysis: a response to Nord. Health Econ. 2012;21(7):878–82.

Article
Google Scholar

Gollier C, Hammitt JK. The long-run discount rate controversy. Annu Rev Resour Econ. 2014;6:273–95.

Article
Google Scholar

Hall RE, Jones CI. The value of health and the rise in health spending. Q J Econ. 2007;122(1):39–72.

Article
Google Scholar

Getzen TE. Health care is an individual necessity and a national luxury: applying multilevel decision models to the analysis of health care expenditures. J Health Econ. 2000;19(2):259–70.

Article
CAS
PubMed
Google Scholar

Baltagi BH, Moscone F. Health care expenditures and income in the OECD reconsidered. Econ Model. 2010;27(4):804–11.

Article
Google Scholar

Acemoglu D, Finkelstein A, Notowidigdo MJ. Income and health spending: evidence from oil price shocks. Rev Econ Stat. 2013;95(4):1079–95.

Article
Google Scholar

Baltagi BH, Lagravinese R, Moscone F, Tosetti E. Health care expenditure and income: a global perspective. Health Econ. 2017;26(7):863–74.

Article
PubMed
Google Scholar

Ramsey FP. A mathematical theory of saving. Econ J. 1928;38(152):543–59.

Article
Google Scholar

Heal G. Climate economics. A meta-review and some suggestions for further research. Rev Environ Econ Policy. 2009;3(1):4–21.

Article
Google Scholar

Arrow KJ, Cline W, Mäler KG, Munasinghe M, Squitieri R, Stiglitz J. Intertemporal equity, discounting, and economic efficiency. In: Bruce JP, Lee H, Haites EF, editors. Climate change: economic and social dimensions of climate change, contribution of Working Group III to the Second Assessment Report of the Intergovernmental Panel on Climate Change. Cambridge: Cambridge University Press; 1996. p. 125–44.

Google Scholar

Arrow KJ, Kurz M. Public investment, the rate of return and optimal fiscal policy. Baltimore: Johns Hopkins University Press; 1970.

Google Scholar

Dasgupta P, Marglin SA, Sen A. Guidelines for project evaluation. New York: United Nations; 1972.

Google Scholar

Lind RC. The rate of discount and the application of social benefit-cost analysis in the context of energy policy decisions. In: Lind RC, Arrow KJ, Corey GR, Dasgupta P, Sen AK, Stauffer T, Stiglitz JE, Stockfisch JA, Wilson J, editors. Discounting for time and risk in energy planning. Baltimore: Johns Hopkins Press for Resources for the Future; 1982. p. 443–58.

Google Scholar

Marglin SA. The opportunity costs of pubic investment. Q J Econ. 1963;77(2):274–89.

Article
Google Scholar

Marglin SA. The social rate of discount and the optimal rate of investment. Q J Econ. 1963;77(1):95–111.

Article
Google Scholar

Arrow KJ, Cropper ML, Gollier C, Groom B, Heal G, Newel R, Nordhaus WD, Pindyck R, Pizer W, Portney P, Sterner T, Tol RSJ, Weitzman ML. Should governments use a declining discount rate in project analysis? Rev Environ Econ Policy. 2014;8(2):145–63.

Article
Google Scholar

Tol RSJ. On dual-rate discounting. Econ Model. 2003;21(1):95–8.

Article
Google Scholar

Weikard HP, Zhu X. Discounting and environmental quality: when should dual rates be used? Econ Model. 2005;22(5):868–78.

Article
Google Scholar

Hoel M, Sterner T. Discounting and relative prices. Clim Change. 2007;84(3):265–80.

Article
Google Scholar

Sterner T, Persson M. Introducing relative prices into the discounting debate. Rev Environ Econ Policy. 2008;2(1):61–76.

Article
Google Scholar

Trager CP. Sustainability, limited substitutability, and non-constant social discount rates. J Environ Econ Manag. 2011;62(2):215–28.

Article
Google Scholar

Baumgärtner S, Klein AM, Thiel D, Winkler K. Ramsey discounting of ecosystem services. Environ Resour Econ. 2015;61(2):273–96.

Article
Google Scholar

Ebert U. Environmental goods and the distribution of income. Environ Resour Econ. 2003;25(4):435–59.

Article
Google Scholar

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). Allgemeine Methoden–Version 5.0. Köln: IQWiG. 2017. https://www.iqwig.de/download/Allgemeine-Methoden_Version-5-0.pdf. Accessed 18 Oct 2017.

Statistisches Bundesamt: Generationensterbetafeln für Deutschland. Modellrechnungen für die Geburtsjahrgänge 1896–2009. Wiesbaden: Statistisches Bundesamt; 2011.

Johansson A, Guillemette Y, Murtin F, Turner F, Nicoletti G, de la Maisonneuve C, Bagnol, P, Bousquet G, Spinelli F. Looking to 2060: long-term global growth prospects. Paris: OECD Economic Policy Papers No. 03; 2012.

Hammitt JK. Valuing mortality risk: theory and practice. Environ Sci Technol. 2000;34(8):1396–400.

Article
CAS
Google Scholar

Robinson LA, Hammitt JK. Research synthesis and the value per statistical life. Risk Anal. 2015;35(6):1086–100.

Article
PubMed
Google Scholar

Doucouliagos H, Stanley TD, Viscusi WK. Publication selection and the income elasticity of the value of a statistical life. J Health Econ. 2014;33:67–75.

Article
PubMed
Google Scholar

Liu JT, Hammitt JK, Liu JL. Estimated hedonic wage function and value of life in a developing country. Econ Lett. 1997;57(3):353–8.

Article
Google Scholar

Miller TR. Variations between countries in values of statistical life. J Transp Econ Policy. 2000;34(2):169–88.

Google Scholar

Bowland BJ, Beghin JC. Robust estimates of a statistical life for developing economies. J Policy Model. 2001;23(4):385–96.

Article
Google Scholar

Mrozek JR, Taylor LO. What determines the value of life? A meta-analysis. J Policy Anal Manag. 2002;1(2):253–70.

Article
Google Scholar

De Blaeij A, Florax RJGM, Rietveld P, Verhoef E. The value of statistical life in road safety: meta-analysis. Accid Anal Prev. 2003;35(6):973–86.

Article
PubMed
Google Scholar

Viscusi WK, Aldy JE. The value of a statistical life: a critical review of market estimates throughout the world. J Risk Uncertain. 2003;27(1):5–76.

Article
Google Scholar

Kluve J, Schaffner S. The value of life in Europe—a meta-analysis. Sozialer Fortschritt. 2008;10–11:279–87.

Article
Google Scholar

Bellavance F, Dionne G, Lebeau M. The value of a statistical life: a meta-analysis with a mixed effects regression model. J Health Econ. 2009;28(2):444–64.

Article
PubMed
Google Scholar

Lindhjem H, Navrud S, Braathen NA, Blausque V. Valuing mortality risk reductions from environmental, transport, and health policies: a global meta-analysis of stated preference studies. Risk Anal. 2001;31(9):1381–407.

Article
Google Scholar

Doucouliagos C, Stanlye TD, Giles M. Are estimates of the value of a statistical life exaggerated? J Health Econ. 2012;31(1):197–206.

Article
PubMed
Google Scholar

Viscusi WK. The role of publication selection bias in estimates of the value of a statistical life. Am J Health Econ. 2015;1(1):27–52.

Article
Google Scholar

Viscusi WK, Masterman CJ. Income elasticities and global values of a statistical life. J Benefit Cost Anal. 2017;8(2):226–50.

Article
Google Scholar

Majumder A, Madheswaran S. Meta-analysis of values of statistical life estimates. IIM Kozhikode Soc Manag Rev. 2017;6(1):110–20.

Article
Google Scholar

Viscusi WK. Best estimate selection bias in the value of a statistical life. J Benefit Cost Anal. 2018;9(2):205–46.

Article
Google Scholar

Masterman CJ, Viscusi JK. The income elasticity of global values of a statistical life: stated preference evidence. J Benefit Cost Anal. 2018;9(3):407–34.

Article
Google Scholar

Kniesner TJ, Viscusi WK, Ziliak JP. Policy relevant heterogeneity in the value of statistical life: new evidence from panel data quantile regressions. J Risk Uncertain. 2010;40(1):16–31.

Article
Google Scholar

Krupnik A, Alberini A, Cropper M, Simon N, O’Brien B, Goeree R, Heintzelman M. Age, health and the willingness to pay for mortality risk reductions: a contingent valuation survey of Ontario residents. J Risk Uncertain. 2002;24(2):161–86.

Article
Google Scholar

Ludwig L, Neumann J. Updating Income Elasticity Estimates in EPA’s BenMAP Air Pollution Benefits Estimation System. Memorandum to N. Fann, Office of Air and Radiation, U.S. Environmental Protection Agency, from Industrial Economics Incorporated. 2012. https://www.epa.gov/ttn/ecas/regdata/Benefits/IncomeElasticityUpdate_Recommendationswithappendices.pdf. Accessed 18 Jan 2017.

Vassanadumrongdee S, Matsuoka S, Shirakawa H. Meta-analysis of contingent valuation studies on air pollution-related morbidity risks. Environ Econ Pol Stud. 2004;6(1):11–47.

Article
Google Scholar

Van Houtven G, Powers J, Jessup A, Yang JC. Valuing avoided morbidity using meta-regression analysis: what can health status measures and QALYs tell us about WTP? Health Econ. 2006;15(8):775–95.

Article
PubMed
Google Scholar

Schaffner S, Spengler H. Using job changes to evaluate the bias of the value of a statistical life. Resour Energy Econ. 2010;32(1):15–27.

Article
Google Scholar

Cameron TA, DeShazo JR, Stiffler P. Demand for health risk reductions: a cross-national comparison between the U.S. and Canada. J Risk Uncertain. 2010;41(3):245–73.

Article
Google Scholar

Chestnut LG, Rowe RD, Breffle WS. Economic valuation of mortality-risk reduction: stated preferences estimates from the United States and Canada. Contemp Econ Policy. 2012;30(3):399–416.

Article
Google Scholar

Hammitt JK, Haninger K. Valuing fatal risk to children and adults: effects of disease, latency, and risk aversion. J Risk Uncertain. 2010;40(1):57–83.

Article
Google Scholar

Liu JT, Hammitt JK, Wang JD, Liu JL. Mother’s willingness to pay for her own and her child’s health: a contingent valuation study in Taiwan. Health Econ. 2000;9(4):319–26.

Article
CAS
PubMed
Google Scholar

Dickie M, Messman VL. Parental altruism and the value of avoiding acute illness: are kids worth more than parents? J Environ Econ Manag. 2004;48(3):1146–74.

Article
Google Scholar

Agee MD, Crocker TD. Children’s health benefits of reducing environmental tobacco smoke exposure: evidence from parents who smoke. Empir Econ. 2007;32(1):217–37.

Article
Google Scholar

Agee MD, Crocker TD. Does parents’ valuation of children’s health mimic their valuation of own health? J Popul Econ. 2008;21(1):231–49.

Article
Google Scholar

Hammitt JK, Haninger K. Willingness to pay for food sensitivity to duration and severity of illness. Am J Agric Econ. 2007;89(5):1170–5.

Article
Google Scholar

Blomquist GC, Dickie M, O’Conor RM. Willingness to pay for improving fatality risks and asthma symptoms: values for children and adults of all ages. Resour Energy Econ. 2011;33(2):410–25.

Article
Google Scholar

Gerking SD, Dickie M. Valuing reductions in environmental risks to children’s health. Annu Rev Resour Econ. 2013;5:245–60.

Article
Google Scholar

Ryen L, Svensson M. The willingness to pay for a quality adjusted life year: a review of the empirical literature. Health Econ. 2015;24(10):1289–301.

Article
PubMed
Google Scholar

Ahlert M, Breyer F, Schwettmann L. How you ask is what you get: willingness-to-pay for a QALY. Soc Sci Med. 2016;150:40–8.

Article
PubMed
Google Scholar

Byrne MM, O’Mally K, Suarez-Almazor ME. Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis. Med Decis Mak. 2005;25(6):655–66.

Article
Google Scholar

King JT, Tsevat J, Lave JR, Roberts MS. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation. Med Decis Mak. 2005;25(6):667–77.

Article
Google Scholar

Bobinac A, Van Exel NJA, Rutten FFH, Brouwer WBF. Willingness to pay for a quality-adjusted life year: the individual perspective. Value Health. 2010;13(8):1046–55.

Article
PubMed
Google Scholar

Shiroiwa T, Sung YK, Fukuda T, Lang HC, Bae SC, Tsutani K. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ. 2010;19(4):422–37.

Article
PubMed
Google Scholar

Haninger K, Hammitt JK. Diminishing willingness to pay per quality-adjusted life year: valuing acute foodborne illness. Risk Anal. 2011;31(9):1363–80.

Article
PubMed
Google Scholar

Zhao FL, Yue M, Yang H, Wang T, Wu JH, Li SC. Willingness to pay per quality adjusted life year: is one threshold enough for decision-making? Results from a study in patients with chronic prostatitis. Med Care. 2011;49(3):267–72.

Article
PubMed
Google Scholar

Bobinac A, Van Exel NJA, Rutten FFH, Brouwer WBF. Valuing qaly gains by applying a societal perspective. Health Econ. 2013;22(10):1272–81.

Article
PubMed
Google Scholar

Thavorncharoensap M, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong P. Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter? Clin Outcomes Res. 2013;5:29–36.

Article
Google Scholar

Shiroiwa T, Igarashi A, Fukuda T, Ikeda S. WTP for a QALY and health states: more money for severer health states? Cost Eff Resour Alloc. 2013;11:1–7.

Article
Google Scholar